GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Biomaxima SA (WAR:BMX) » Definitions » Cyclically Adjusted FCF per Share

Biomaxima (WAR:BMX) Cyclically Adjusted FCF per Share : zł-0.04 (As of Mar. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Biomaxima Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Biomaxima's adjusted free cash flow per share for the three months ended in Mar. 2024 was zł-0.034. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is zł-0.04 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Biomaxima's average Cyclically Adjusted FCF Growth Rate was -114.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2024-09-21), Biomaxima's current stock price is zł15.30. Biomaxima's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was zł-0.04. Biomaxima's Cyclically Adjusted Price-to-FCF of today is .

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Biomaxima was 228.00. The lowest was 42.46. And the median was 78.31.


Biomaxima Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Biomaxima's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biomaxima Cyclically Adjusted FCF per Share Chart

Biomaxima Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - -0.31 0.37 -0.01

Biomaxima Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.27 0.10 0.10 -0.01 -0.04

Competitive Comparison of Biomaxima's Cyclically Adjusted FCF per Share

For the Diagnostics & Research subindustry, Biomaxima's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biomaxima's Cyclically Adjusted Price-to-FCF Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Biomaxima's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Biomaxima's Cyclically Adjusted Price-to-FCF falls into.



Biomaxima Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Biomaxima's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.034/149.0435*149.0435
=-0.034

Current CPI (Mar. 2024) = 149.0435.

Biomaxima Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 0.043 101.180 0.063
201409 -0.193 100.611 -0.286
201412 0.130 100.122 0.194
201503 0.086 100.041 0.128
201506 0.081 100.448 0.120
201509 0.068 99.634 0.102
201512 0.471 99.471 0.706
201603 0.223 98.983 0.336
201606 -0.099 99.552 -0.148
201609 -0.038 99.064 -0.057
201612 0.205 100.366 0.304
201703 -0.035 101.018 -0.052
201706 0.014 101.180 0.021
201709 -0.030 101.343 -0.044
201712 -0.038 102.564 -0.055
201803 -0.218 102.564 -0.317
201806 -1.071 103.378 -1.544
201809 -1.470 103.378 -2.119
201812 -1.407 103.785 -2.021
201903 0.195 104.274 0.279
201906 0.142 105.983 0.200
201909 0.220 105.983 0.309
201912 0.309 107.123 0.430
202003 0.422 109.076 0.577
202006 -0.900 109.402 -1.226
202009 0.942 109.320 1.284
202012 0.188 109.565 0.256
202103 0.927 112.658 1.226
202106 -0.324 113.960 -0.424
202109 -0.137 115.588 -0.177
202112 -1.521 119.088 -1.904
202203 6.265 125.031 7.468
202206 1.907 131.705 2.158
202209 -0.839 135.531 -0.923
202212 -1.218 139.113 -1.305
202303 -1.252 145.950 -1.279
202306 -1.492 147.009 -1.513
202309 -0.236 146.113 -0.241
202312 -0.843 147.741 -0.850
202403 -0.034 149.044 -0.034

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Biomaxima  (WAR:BMX) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Biomaxima was 228.00. The lowest was 42.46. And the median was 78.31.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Biomaxima Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Biomaxima's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Biomaxima Business Description

Traded in Other Exchanges
N/A
Address
5 Vetterow Street, Lublin, POL, 20-277
Biomaxima SA is a Polish company, produces microbiology media as well as a wide range of reagents and in Vitro diagnostics equipment. The company is also a distributor of products of recognized global diagnostics companies such as Nova Biomedical, Mitsubishi Chemical and Biologist. Its products include Systems Antibiotic Susceptibility Testing, Urine Analysis Systems, Hematological Reagents along with Analyzers, ion Selective Analyzers with Reagents, Immunological Analyzer of Cardiac markers with reagents, Glucose Meters and analyzers for Gasometric and Critical Blood Tests.

Biomaxima Headlines

No Headlines